Ophthalmology Doctors in Muncie, IN Accepting Medicare

7 Ophthalmology doctors found. Showing 1 - 7

Dr. Michael J Hodkin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5091 W Bethel Ave Ste 150, Muncie, IN 47304 Phone: 317-841-2020    Fax: 317-570-7433

Dr. Michael J Scanameo, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 N Tillotson Ave, Muncie, IN 47304 Phone: 765-286-8888    Fax: 765-747-7962

Ajit Kumar Tiwari, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3700 N Everbrook Ln, Muncie, IN 47304 Phone: 765-281-1181    Fax: 765-282-4768

Dr. Vasilis Makris, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3300 W Purdue Ave, Muncie, IN 47304 Phone: 765-288-1935    Fax: 765-289-5032

Dr. Rita Singh-parikshak, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 N Tillotson Ave, Muncie, IN 47304 Phone: 765-286-8888    Fax: 765-747-7962

Dr. Lynnette M Watkins, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 200 N Tillotson Ave, Muncie, IN 47304 Phone: 765-286-8888    Fax: 765-747-7962

Thomas E Strayer, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3525 W. Purdue Ave, Muncie, IN 47304 Phone: 765-288-1800    Fax: 765-288-4680

News Archive

Mirna, Silence enter agreement to assess delivery systems for novel microRNAs

Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, today announced that it has entered into an agreement with Mirna Therapeutics Inc., a biopharmaceutical company pioneering microRNA-based therapeutics for cancer, to assess the delivery capabilities of Silence's proprietary AtuPLEX and DBTC delivery systems for Mirna's novel microRNAs.

Liquid biopsies provide more information about disease course in non-invasive manner

A new study, to be presented at the ESMO 19th World Congress on Gastrointestinal Cancer, shows that so-called "liquid biopsies", blood tests that detect circulating tumour DNA (ctDNA), may not only sound an early alert that a treatment's effect is diminishing, but may also help explain why -sometimes offering clues about what to do next.

Medical researchers identify genetic marker associated with sporadic breast cancer

Medical researchers at the University of Alberta have pinpointed a genetic marker for sporadic breast cancer - one of a handful identified to date in Caucasians.

New clue for cellular damage in Huntington's disease

"Huntington's disease presents an ideal vantage point to study neurodegenerative disease, because we know the misfolded protein that's responsible," says Martin Duennwald, formerly a postdoctoral researcher in the lab of Whitehead Member Susan Lindquist.

Behavioural support programme to make TB patients quit smoking receives BUPA Foundation prize

The BUPA Foundation has awarded a high commendation prize for research led by the University of York into effective ways of helping tuberculosis patients in Pakistan to give up smoking.

Read more Medical News

› Verified 8 days ago